An Overview of Lassa fever, an Rising Old World Haemorrhagic Viral Disease

Lassa fever is an acute immunosuppressive illness of increasing public health concern causing severe morbidity and significant mortality especially in epidemic cases. Lassa fever is an acute viral zoonotic illness caused by Lassa virus, an arenavirus known to be responsible for a severe haemorrhagic fever characterised by fever, muscle aches, sore throat, nausea, vomiting, chest and abdominal pain. The virus exhibits persistent, asymptomatic infection with profuse urinary virus excretion in the ubiquitous rodent vector, Mastomys natalensis. Lassa fever is endemic in West Africa and has been reported from Sierra Leone, Guinea, Liberia, and Nigeria. The virus replicates through a strategy known as the Ambisense, where two RNA strands code for genes in both the sense and antisense direction that is rapid and demonstrate temporal control in replication. Different diagnostic tests for the virus are available, which range from viral culture to serological and molecular diagnostic tests. There is an urgent need to develop drugs and vaccines against the virus because the World Health Organization (WHO) has identified Lassa virus as one of the viruses that is likely to cause a future epidemic, although a research is ongoing to evaluate Lassa virus vaccine immunogenicity in the CBA/J-ML29 mouse model. This review gives an overview on the structure, replication cycle, pathogenesis and diagnosis of the virus. Keywords: Lassa fever, Lassa virus, Arenavirus, Replication, Pathogenesis, Diagnosis

[1]  Abraham M. Nussbaum The Wayback Machine , 2022, Perspectives in biology and medicine.

[2]  Laura Mazzola,et al.  Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings , 2019, BMJ Global Health.

[3]  D. Jain,et al.  Zika virus (ZIKV) disease: past, present and future , 2018, Journal of Drug Delivery and Therapeutics.

[4]  E. Zaky Autism Spectrum Disorder (ASD); The Past, The Present, and The Future , 2017 .

[5]  A. Dongo,et al.  Lassa fever presenting as acute abdomen: a case series , 2013, Virology Journal.

[6]  E. Saphire,et al.  Hiding the evidence: two strategies for innate immune evasion by hemorrhagic fever viruses , 2012, Current Opinion in Virology.

[7]  Donald S. Grant,et al.  Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection , 2011, Virology Journal.

[8]  Mark A. Smith,et al.  Pathogenesis of lassa fever in cynomolgus macaques , 2011, Virology Journal.

[9]  H. Ly,et al.  Cap binding and immune evasion revealed by Lassa nucleoprotein structure , 2010, Nature.

[10]  S. Günther,et al.  Lassa Fever, Nigeria, 2005–2008 , 2010, Emerging infectious diseases.

[11]  S. Günther,et al.  T Cell-Dependence of Lassa Fever Pathogenesis , 2010, PLoS pathogens.

[12]  S. Kunz,et al.  Cell entry by human pathogenic arenaviruses , 2008, Cellular microbiology.

[13]  V. Georgiev,et al.  National Institute of Allergy and Infectious Diseases, NI , 2008 .

[14]  O. Ogbu,et al.  Lassa fever in West African sub-region: an overview. , 2007, Journal of vector borne diseases.

[15]  Update on Lassa fever in West Africa. , 2005, Releve epidemiologique hebdomadaire.

[16]  M. Georges-Courbot,et al.  Lassa Virus Infection of Human Dendritic Cells and Macrophages Is Productive but Fails to Activate Cells1 , 2004, The Journal of Immunology.

[17]  Debbie Baglole,et al.  Lassa fever: epidemiology, clinical features, and social consequences , 2003, BMJ : British Medical Journal.

[18]  B. Pulendran,et al.  Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1 , 2003, The Journal of Immunology.

[19]  M. Buchmeier,et al.  Arenaviridae: The viruses and their replication , 2001 .

[20]  S. Günther,et al.  Imported lassa fever in Germany: molecular characterization of a new lassa virus strain. , 2000, Emerging infectious diseases.

[21]  T. Ksiazek,et al.  Diagnosis and Clinical Virology of Lassa Fever as Evaluated by Enzyme-Linked Immunosorbent Assay, Indirect Fluorescent-Antibody Test, and Virus Isolation , 2000, Journal of Clinical Microbiology.

[22]  A. Mocroft,et al.  Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. , 1999, AIDS.

[23]  J. Meulen,et al.  Detection of Lassa Virus Antinucleoprotein Immunoglobulin G (IgG) and IgM Antibodies by a Simple Recombinant Immunoblot Assay for Field Use , 1998, Journal of Clinical Microbiology.

[24]  C. Peters,et al.  Phylogenetic analysis of the Arenaviridae: patterns of virus evolution and evidence for cospeciation between arenaviruses and their rodent hosts. , 1997, Molecular phylogenetics and evolution.

[25]  D. Brown,et al.  Early diagnosis of Lassa fever by reverse transcription-PCR , 1994, Journal of clinical microbiology.

[26]  J. McCormick,et al.  Evaluation of the polymerase chain reaction for diagnosis of Lassa virus infection. , 1993, The American journal of tropical medicine and hygiene.

[27]  M. Buchmeier,et al.  Glycoproteins of the Arenaviruses , 1993 .

[28]  S. Fisher-Hoch,et al.  Unexpected adverse reactions during a clinical trial in rural west Africa. , 1992, Antiviral research.

[29]  S. Wilson,et al.  Nucleotide sequence of the S RNA of Lassa virus (Nigerian strain) and comparative analysis of arenavirus gene products. , 1991, Virus research.

[30]  J. McCormick,et al.  Antigenic relatedness between arenaviruses defined at the epitope level by monoclonal antibodies. , 1991, The Journal of general virology.

[31]  F. Hufert,et al.  Detection of Lassa virus RNA in specimens from patients with Lassa fever by using the polymerase chain reaction , 1990, Journal of clinical microbiology.

[32]  L. Brammer,et al.  Lassa fever in the United States. Investigation of a case and new guidelines for management. , 1990, The New England journal of medicine.

[33]  D. Kochhar Effects of exposure to high concentrations of ribavirin in developing embryos , 1990, The Pediatric infectious disease journal.

[34]  J. McCormick,et al.  Nucleotide sequence of the Lassa virus (Josiah strain) S genome RNA and amino acid sequence comparison of the N and GPC proteins to other arenaviruses. , 1989, Virology.

[35]  J. McCormick,et al.  Viral hemorrhagic fever antibodies in Nigerian populations. , 1988, The American journal of tropical medicine and hygiene.

[36]  J. McCormick,et al.  A case-control study of the clinical diagnosis and course of Lassa fever. , 1987, The Journal of infectious diseases.

[37]  E. S. Smith,et al.  A prospective study of the epidemiology and ecology of Lassa fever. , 1987, The Journal of infectious diseases.

[38]  J. McCormick Epidemiology and control of Lassa fever. , 1987, Current topics in microbiology and immunology.

[39]  J. McCormick,et al.  Nucleotide sequence of the glycoprotein gene and intergenic region of the Lassa virus S genome RNA. , 1986, Virology.

[40]  D. Gajdusek,et al.  Hemorrhagic fever virus infections in an isolated rainforest area of central Liberia. Limitations of the indirect immunofluorescence slide test for antibody screening in Africa. , 1986, Tropical and geographical medicine.

[41]  J. McCormick,et al.  Lassa fever. Effective therapy with ribavirin. , 1986, The New England journal of medicine.

[42]  P. Jahrling,et al.  EARLY DIAGNOSIS OF HUMAN LASSA FEVER BY ELISA DETECTION OF ANTIGEN AND ANTIBODY , 1985, The Lancet.

[43]  P. Jahrling,et al.  Endemic Lassa fever in Liberia. III. Characterization of Lassa virus isolates. , 1985, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[44]  P. Jahrling,et al.  Detection of Lassa virus antigens and Lassa virus-specific immunoglobulins G and M by enzyme-linked immunosorbent assay , 1984, Journal of clinical microbiology.

[45]  D. Bishop,et al.  The sequences of the N protein gene and intergenic region of the S RNA of pichinde arenavirus. , 1984, Virology.

[46]  A. Anusz [Lassa fever]. , 1981, Pielegniarka i polozna.

[47]  P. Jahrling,et al.  Lassa virus infection of rhesus monkeys: pathogenesis and treatment with ribavirin. , 1980, The Journal of infectious diseases.

[48]  J. V. Lange,et al.  Indirect immunofluorescence for the diagnosis of Lassa fever infection. , 1975, Bulletin of the World Health Organization.

[49]  D. E. Carey,et al.  An outbreak of Lassa fever on the Jos plateau, Nigeria, in January-February 1970. A preliminary report. , 1970, The American journal of tropical medicine and hygiene.